| Literature DB >> 24483776 |
Christine D Jones1, George M Holmes, Darren A DeWalt, Brian Erman, Jia-Rong Wu, Crystal W Cene, David W Baker, Dean Schillinger, Bernice Ruo, Kirsten Bibbins-Domingo, Aurelia Macabasco-O'Connell, Victoria Hawk, Kimberly Broucksou, Michael Pignone.
Abstract
BACKGROUND: Weight monitoring is an important element of HF self-care, yet the most clinically meaningful way to evaluate weight monitoring adherence is uncertain. We conducted this study to evaluate the association of (1) self-reported recall and (2) daily diary-recorded weight monitoring adherence with heart failure-related (HF-related) hospitalization.Entities:
Mesh:
Year: 2014 PMID: 24483776 PMCID: PMC3912256 DOI: 10.1186/1471-2261-14-12
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Baseline characteristics of individuals: optimal and Sub-optimal weight monitoring adherence from self-reported and diary-recorded measures
| Age (mean, SD) | 62.2 (13.9) | 62.4 (13.9) | 61.1 (13.5) | 0.638 | 64.3 (12.6) | 60.1 (14.8) | 0.024 |
| Men (N, %) | 103 (48) | 83 (45) | 20 (63) | 0.069 | 45 (42) | 58 (53) | 0.101 |
| Race/Ethnicity | | | | | | | |
| White, Non-Hispanic | 80 (37) | 71 (39) | 9 (28) | 0.024 | 47 (44) | 33 (30) | 0.071 |
| Hispanic | 35 (16) | 24 (13) | 11 (34) | | 12 (11) | 23 (21) | |
| African American | 87 (40) | 76 (41) | 11 (34) | | 43 (40) | 44 (40) | |
| Other | 14 (6) | 13 (7) | 1 (3) | | 5 (5) | 9 (8) | |
| NYHA Class (N, %) | | | | | | | |
| I | 45 (21) | 39 (21) | 6 (19) | 0.536 | 23 (21) | 22 (20) | 0.168 |
| II | 111 (51) | 96 (52) | 15 (47) | | 61 (57) | 50 (46) | |
| III | 35 (16) | 27 (15) | 8 (25) | | 15 (14) | 20 (18) | |
| IV | 25 (12) | 22 (12) | 3 (9) | | 8 (7) | 17 (16) | |
| Study site (N, %) | | | | | | | |
| UNC | 87 (40) | 80 (43) | 7 (22) | <0.001a | 56 (52) | 31 (28) | <0.001 |
| Northwestern University | 66 (31) | 62 (34) | 4 (13) | | 33 (31) | 33 (30) | |
| UCSF | 39 (18) | 22 (12) | 17 (53) | | 6 (6) | 33 (30) | |
| Olive view, UCLA | 24 (11) | 20 (11) | 4 (13) | | 12 (11) | 12 (11) | |
| Socioeconomic status, median (IQR) | 4 (3, 6) | 5 (3,7) | 4 (1, 5) | 0.026b | 4 (2, 6) | 4 (3, 6) | 0.455b |
| Inadequate literacy (N, %) | 74 (34) | 59 (32) | 15 (47) | 0.103 | 30 (28) | 44 (40) | 0.06 |
| Heart failure related QOL: Heart failure symptom scale, median (IQR) | 61 (43, 79) | 61(46, 79) | 59 (43, 75) | 0.272b | 64 (46, 82) | 57 (43, 71) | 0.014b |
| Income level | | | | | | | |
| <$15,000 | 101 (47) | 79 (43) | 22 (69) | 0.052 | 43 (40) | 58 (53) | 0.098 |
| $15,000-$24,999 | 40 (19) | 34 (18) | 6 (19) | | 20 (19) | 20 (18) | |
| >$25,000 | 71 (33) | 67 (36) | 4 (12) | | 41 (38) | 30 (28) | |
| Previous MI/Angina (N, %) | 83 (38) | 76 (41) | 7 (22) | 0.037 | 49 (46) | 34 (31) | 0.027 |
| Systolic dysfunction (N, %) | 123 (57) | 112 (61) | 11 (34) | 0.005 | 65 (61) | 58 (53) | 0.263 |
| ACE-Inhibitor or ARB (N, %) | 178 (82) | 154 (84) | 24 (75) | 0.233 | 86 (80) | 92 (84) | 0.437 |
| Beta-Blocker (N, %) | 176 (81) | 153 (83) | 23 (72) | 0.130 | 90 (84) | 86 (79) | 0.324 |
| Thiazide | 22 (10) | 18 (10) | 4 (13) | 0.750 | 10 (9) | 12 (11) | 0.823 |
| Spironolactone | 50 (23) | 46 (25) | 4 (13) | 0.172 | 22 (21) | 28 (25) | 0.425 |
| Telephone calls with educator, median (IQR) | 16 (14, 18) | 16 (15, 18) | 15 (13, 16) | <0.001b | 17 (16, 18) | 15 (13, 17) | <0.001b |
| Self-reported weighing daily or more at baseline, (N, %) | 61 (28) | 58 (32) | 3 (9) | 0.005a | 35 (33) | 26 (24) | 0.148 |
| Taught weight-based diuretic self-adjustment | 178 (82) | 152 (83) | 26 (81) | 0.852 | 87 (81) | 91 (83) | 0.674 |
aGroups compared using Fisher’s exact test.
bGroups compared using both t-test and Wilcoxon-Mann–Whitney test.
NYHA: New York Heart Association; MI: Myocardial Infarction; ACE: Angiotensin-Converting Enzyme; ARB: Angiotensin Receptor Blocker; IQR: Interquartile Range; QOL: Quality of Life.
Association of weight monitoring adherence with HF hospitalizations, self-reported and diary-recorded
| | | | |
| Adjusted for site only | 216 | 1.99 | (0.69-5.72) |
| Overall adjusteda | 206 | 1.34 | (0.24-7.32) |
| | | | |
| Adjusted for site only | 216 | 0.32 | (0.15-0.70) |
| Overall adjusteda | 206 | 0.37 | (0.18-0.75) |
aModel adjusted for age, gender, race, site, subjective SES, HF quality of life, previous MI/angina, systolic dysfunction, and self-reported weight monitoring adherence (daily or more) at baseline.
Association of weight monitoring adherence with HF hospitalizations, sensitivity analyses
| | | |
| ≥ 90%a | 0.24 | (0.11-0.54) |
| ≥ 80% (main analysis)a | 0.37 | (0.18-0.75) |
| ≥ 70%a | 0.41 | (0.25-0.67) |
| ≥ 60%a | 0.42 | (0.25-0.70) |
aModel adjusted for age, gender, race, site, subjective SES, HF quality of life, previous MI/Angina, systolic dysfunction, and self-reported weight monitoring adherence (daily or more) at baseline.
Figure 1Association of heart failure-related hospitalization with diary-recorded adherence over 12 months, adjusted incidence rate ratio. aModel adjusted for age, gender, race, site, subjective SES, HF quality of life, previous MI/angina, systolic dysfunction, and self-reported weight monitoring adherence (daily or more) at baseline.